US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,043.52

-9.3038-0.45%

Number of Gainers:- -

Number of Losers:10

Number of Flat:1

PE:- -

High:2,070.22

Open:2,050.62

Low:2,021.12

Close:2,052.83

Volume:21.41M

Turnover:1.10B

Market Cap:225.16B

Float Cap:224.46B

Loading ...

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared to Competitors

Quest Diagnostics announces executive transition and leadership continuity

Quest Diagnostics EVP Catherine Doherty to Retire in July 2027

Inovio Adds Delaware Chancery Court Exclusive-Forum Bylaw for Key Shareholder Suits

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live

Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs

THOMSON REUTERS

Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences

THOMSON REUTERS

Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares

Emergent BioSolutions SVP Paul Anthony Williams Disposes of 3,000 Common Shares for $19,590

UBS Adjusts Price Target on Viatris to $26 From $23, Keeps Buy Rating

MT Newswires Live

Harrow Closes Tyrvaya Nasal Spray Acquisition from Viatris for USD 30 Million Upfront

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Viatris to Report Third-Quarter Financial Results, Host Conference Call and Webcast

Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Could Be Quite Risky

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sgp.itiger.com/stock/BK4583/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2043.5231,"timestamp":1791316799999,"preClose":2052.827,"halted":0,"volume":21413190,"delay":0,"changeRate":-0.004532,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-9.303833,"latestTime":"10-06 16:00:00 EDT","open":2050.6243,"high":2070.216,"low":2021.115,"amount":1100631834.295964,"amplitude":0.023919,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.581376,"peRate":-74.672799,"turnoverRate":0.007924,"increases":0,"decrements":10,"flats":0,"marketCap":225159191282,"floatMarketCap":224459713256},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":2070.216,"amplitude":0.023919,"preClose":2052.827,"low":2021.115,"pbRate":"6.581376","latestPrice":2043.5231,"volume":21413190,"delay":0,"open":2050.6243,"prevYearClose":1682.3505,"prevWeekClose":2054.7417,"prevMonthClose":2104.65,"prevQuarterClose":2104.65,"fiveDayClose":2132.7578,"twentyDayClose":2059.5327,"sixtyDayClose":1859.0768,"secType":"PLATE","market":"US","turnoverRate":0.007924,"peRate":-74.672799,"marketCap":225159191282,"floatMarketCap":224459713256,"timestamp":1791316799999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":0,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673492067","title":"Gilead : JP Morgan Raises Target Price to $170 from $160","url":"https://stock-news.laohu8.com/highlight/detail?id=2673492067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673492067?lang=en_us&edition=fundamental","pubTime":"2026-10-07 12:19","pubTimestamp":1791346754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T08V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4139","IBBQ","IBB","LU1430594728.SGD","BIB","LU1061106388.HKD","IE0002270589.USD","LU1585245621.USD","LU0965509101.SGD","BBH","LU0889565916.HKD","LU1674673691.USD","LU0320765992.SGD","BK4583","LU2468319806.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU0965508806.USD","LU1778281490.HKD","LU1934455277.USD","SG9999015952.SGD","LU1066053197.SGD","SG9999015986.USD","LU1023059063.AUD","LU0058720904.USD","BK4585","LU2324357040.USD","LU0122379950.USD","LU0114720955.EUR","BMED","GILD","LU2357627491.SGD","BK4578","TBXU","LU1037948541.HKD","LU1674673428.USD","BK4588","LU0882574055.USD","LU0861579265.USD","LU0823416689.USD","LU1934455863.HKD","LU0109394709.USD","TMED","MEDI","LU1037948897.HKD","LU2087621335.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673066891","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066891?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:25","pubTimestamp":1791321900,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 1.74% to $1.13 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.45% to 27,599.79 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.This was the stock's fourth consecutive day of losses.Inovio Pharmaceuticals Inc. closed 58.46% short of its 52-week high of $2.72, which the company achieved on December 17th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.73% to $254.78, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.33% to $27.50.Trading volume  remained 2.5 million below its 50-day average volume of 4.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","BK4139","BK4568","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065127","title":"Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065127?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:01","pubTimestamp":1791320460,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  shed 1.28% to $228.39 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,818.93 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.This was the stock's second consecutive day of losses.Quest Diagnostics Inc. closed 8.22% below its 52-week high of $248.84, which the company achieved on September 21st.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc.  fell 0.60% to $376.32, IQVIA Holdings Inc.  fell 2.30% to $259.98, and Centene Corp.  rose 0.48% to $64.61.Trading volume  eclipsed its 50-day average volume of 986,082.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952097.USD","BK4583","LU1854103824.USD","BK4196","LU2506952170.USD","LU2506951958.HKD","BK4567","BK4585","LU0823417653.USD","LU2506951875.HKD","LU0823417737.USD","LU1854104046.USD","BK4588","DGX","LU0950375773.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673414065","title":"Quest Diagnostics announces executive transition and leadership continuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2673414065","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673414065?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:59","pubTimestamp":1791320381,"startTime":"0","endTime":"0","summary":"Quest Diagnostics ( ($DGX) ) has provided an announcement. On October 6, 2026, Quest Diagnostics announced that long-time executive Catherine T. Do...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quest-diagnostics-announces-executive-transition-and-leadership-continuity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quest-diagnostics-announces-executive-transition-and-leadership-continuity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1854103824.USD","BK4583","LU0950375773.USD","LU2506951958.HKD","LU1854104046.USD","LU0823417653.USD","LU2506952170.USD","BK4588","BK4196","LU2506952097.USD","DGX","LU2506951875.HKD","BK4567","LU0823417737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673806588","title":"Quest Diagnostics EVP Catherine Doherty to Retire in July 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673806588","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673806588?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:32","pubTimestamp":1791318734,"startTime":"0","endTime":"0","summary":"Quest Diagnostics EVP Catherine Doherty to retire in July 2027Quest Diagnostics disclosed that Catherine T. Doherty will retire in July 2027.Effective Nov. 1, 2026, Doherty will shift to Executive Vice President.New remit includes health systems, the Corewell Health joint venture, and Project Nova to modernize order-to-cash processes and IT.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL3294Pc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952170.USD","BK4585","BK4588","LU0950375773.USD","LU1854103824.USD","LU2506951875.HKD","BK4567","LU0823417653.USD","BK4583","DGX","BK4196","LU2506951958.HKD","LU0823417737.USD","LU1854104046.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673999063","title":"Inovio Adds Delaware Chancery Court Exclusive-Forum Bylaw for Key Shareholder Suits","url":"https://stock-news.laohu8.com/highlight/detail?id=2673999063","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673999063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:08","pubTimestamp":1791317299,"startTime":"0","endTime":"0","summary":"Inovio adds Delaware Chancery Court exclusive-forum bylaw for key shareholder suitsInovio adopted a bylaw amendment effective Oct. 6, 2026, adding an exclusive-forum provision for specified corporate ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL2n5mFs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","INO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051269","title":"Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051269","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051269?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:29","pubTimestamp":1791293347,"startTime":"0","endTime":"0","summary":"Cognizant Technology Solutions  said Tuesday that it has signed a five-year extension agreement with Gilead Sciences  to support DevOps capabilities and the use of agentic artificial intelligence tools for certain technology programs.Cognizant said the updated scope will focus on uses intended to simplify processes, improve delivery, and help Gilead conduct priority technology programs more efficiently.Shares of Cognizant and Gilead were up 1.9% and 0.2% respectively in premarket activity Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","TMED","LU1934455194.USD","LU0058720904.USD","MEDI","GILD","IBBQ","BK4134","BK4583","LU1057294990.SGD","LU1674673691.USD","LU0072462343.USD","LU1267930656.SGD","VTHR","LU0965509010.AUD","TBXU","AGIX","LU2506951875.HKD","BK4578","LU0702159699.USD","LU0889565916.HKD","LU0965509101.SGD","LU0950375773.USD","AIPO","BBH","LU1061106388.HKD","LU0823416689.USD","SG9999015978.USD","LU2506951958.HKD","LU2506952170.USD","ARTY","BMED","LU2468319806.SGD","LU1674673428.USD","CTSH","LU0006061336.USD","LU0320765992.SGD","LU1048596156.SGD","SG9999015945.SGD","BIB","LU1066053197.SGD","IBB","LU0536402901.SGD","LU1166156734.SGD","CHAT","LU2087621335.USD","QTOC","LU0882574055.USD","LU1037948541.HKD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673374051","title":"Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673374051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673374051?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:00","pubTimestamp":1791291624,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA6LBGRG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2506952170.USD","CTSH","SG9999015978.USD","BK4568","LU1839511570.USD","LU2468319806.SGD","LU2506951958.HKD","LU1934455863.HKD","BK4532","LU1066051498.USD","IE00BKVL7J92.USD","BMED","BIB","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU1102505929.USD","LU0287143357.SGD","LU0861579265.USD","LU1778281490.HKD","LU1674673691.USD","IBB","LU0536402901.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","LU1585245621.USD","LU0197229882.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU0823417737.USD","LU0882574055.USD","TMED","LU1102505762.USD","BK4566","IBBQ","GILD","LU0072462343.USD","LU0320765992.SGD","BK4583","LU0006061336.USD","LU0122379950.USD","LU2506951875.HKD","TBXU","SG9999015986.USD","BK4134","SG9999015945.SGD","LU1048588211.SGD","IE00B3T34201.USD","BBH","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673059715","title":"Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673059715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673059715?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:00","pubTimestamp":1791291624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA6LBGRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","BIB","LU0889565916.HKD","LU0950375773.USD","LU1066053197.SGD","BMED","LU1023059063.AUD","BK4139","LU0702159343.USD","LU0122379950.USD","LU0823416689.USD","MEDI","CTSH","LU0965509010.AUD","LU1805238398.USD","LU2468319806.SGD","LU0289739699.SGD","SG9999015952.SGD","LU1839511570.USD","LU0708995666.HKD","LU1267930656.SGD","LU0006061336.USD","SG9999015978.USD","LU1430594728.SGD","LU2112291526.USD","IE00BZ1G4Q59.USD","BK4578","IE0002270589.USD","TMED","BK4568","LU0823417653.USD","BK4583","GILD","LU1778281490.HKD","LU1102505762.USD","LU2506952170.USD","LU0823417737.USD","LU0861579265.USD","LU1934455277.USD","SG9999015945.SGD","LU1934455194.USD","BK4532","BBH","LU2089984988.USD","IBBQ","IE00BKVL7J92.USD","IBB","BK4585","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673056512","title":"Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056512","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056512?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:03","pubTimestamp":1791288212,"startTime":"0","endTime":"0","summary":"Entera Bio appoints ex-Gilead executive Laura Hamill to board of directorsEntera Bio named former Gilead EVP Laura Hamill to its board, effective Dec. 1, 2026.Hamill brings 35+ years in global commerc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL2M8X8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU2324357040.USD","LU0234570918.USD","LU1934455277.USD","LU1839511570.USD","LU0122379950.USD","LU1037948541.HKD","LU0889565916.HKD","LU1066053197.SGD","LU1571399168.USD","LU0965509283.SGD","LU0882574055.USD","LU0965509101.SGD","IBBQ","IE00B3T34201.USD","LU1674673428.USD","BIB","LU1934455194.USD","IE0002270589.USD","LU1061106388.HKD","LU0859254822.USD","SG9999015945.SGD","LU1037948897.HKD","TBXU","BK4588","TMED","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0109394709.USD","LU1934455863.HKD","BMED","BK4583","LU1778281490.HKD","LU2357627491.SGD","MEDI","LU1430594728.SGD","GILD","BBH","LU1585245621.USD","LU1057294990.SGD","BK4578","LU0861579265.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","LU0823416689.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","IE00B19Z3B42.SGD","ENTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1778281490.HKD","IDNA","BK4551","IE00B19Z3B42.SGD","MRNY","IBBQ","LU0861579265.USD","BK4585","LU0965509101.SGD","LU1934455277.USD","LU2087621335.USD","BK4588","BK4578","BK4533","LU1839511570.USD","BK4139","LU1057294990.SGD","SG9999015945.SGD","LGHT","LU1674673691.USD","TBXU","BIB","MEDI","LU1066051498.USD","LU2357627491.SGD","BK4568","BK4532","BBH","IBB","LU1037948897.HKD","GILD","GNOM","MRNA","BK4583","LU1674673428.USD","TMED","IE00B7SZLL34.SGD","LU1061106388.HKD","LU0965509010.AUD","LU2324357040.USD","LU0823416689.USD","SG9999015952.SGD","IE00BZ1G4Q59.USD","MRNX","WDNA","BMED","LU0109394709.USD","LU2112291526.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673817430","title":"Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673817430","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673817430?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:11","pubTimestamp":1791231084,"startTime":"0","endTime":"0","summary":"Aethlon Medical says shareholders reject proposal to authorize 20,000,000 preferred sharesAethlon Medical filed an amended 8-K to correct its prior disclosure on a shareholder vote at the 2026 annual ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL6k3Z0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4583","BK4568","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673470097","title":"Emergent BioSolutions SVP Paul Anthony Williams Disposes of 3,000 Common Shares for $19,590","url":"https://stock-news.laohu8.com/highlight/detail?id=2673470097","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673470097?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:17","pubTimestamp":1791206272,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions SVP Paul Anthony Williams disposes of 3,000 common shares for $19,590Emergent BioSolutions SVP, Products Business Paul Anthony Williams sold 3,000 common shares on Oct. 1, 2026.S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLBcFNv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Emergent BioSolutions SVP Paul Anthony Williams Disposes of 3,000 Common Shares for $19,590","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700565","title":"UBS Adjusts Price Target on Viatris to $26 From $23, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700565","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700565?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:07","pubTimestamp":1791205648,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) has an average rating of overweight and mean price target of $20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1839511570.USD","BK4585","BK4583","BK4007","VTRS","LU2087621335.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704540","title":"Harrow Closes Tyrvaya Nasal Spray Acquisition from Viatris for USD 30 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704540","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704540?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:06","pubTimestamp":1791198406,"startTime":"0","endTime":"0","summary":"Harrow closes TYRVAYA nasal spray acquisition from Viatris for USD 30 million upfrontHarrow closed its acquisition of TYRVAYA (varenicline solution) nasal spray 0.03 mg from Viatris, gaining worldwide","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL3Mdldj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","BK4112","LU2210149790.SGD","IE00BN0W2T93.GBP","LU1839511570.USD","IE00BKPKM429.USD","IE00BN0W2W23.USD","BK4557","IE00BQXX3C00.GBP","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","BK4585","BK4588","IE00B3QW5Z07.USD","LU2087621335.USD","BCDF","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4007","LU0314104364.USD","LU2210150020.SGD","IE00BQXX3F31.USD","BK4583","SG9999014005.SGD","SG9999014039.USD","HROW","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","SG9999014021.USD","BK4585","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","MEDI","LU2087621335.USD","LU0314104364.USD","LU1934455194.USD","LU2468319806.SGD","BBH","BK4112","GILD","LU2210150020.SGD","BK4583","LU0965509010.AUD","LU1037948541.HKD","TMED","BK4566","IE0002270589.USD","IE00BQXX3D17.EUR","NRIX","BCDF","BIB","BMED","LU1057294990.SGD","NDAQ","TBXU","IBBQ","LU1839511570.USD","IE00BZ1G4Q59.USD","LU1934455277.USD","LU0861579265.USD","LU0058720904.USD","LU1037948897.HKD","SG9999015986.USD","BK4578","BK4568","LU1066051498.USD","LU1430594728.SGD","SG9999015945.SGD","LU0882574055.USD","LU0965509283.SGD","IE00BN0W2W23.USD","LU0965509101.SGD","IBB","LU0859254822.USD","SG9999015978.USD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139","LU0289739699.SGD","LU1585245621.USD","MEDI","LU1061106388.HKD","BBH","LU0122379950.USD","BK4550","LU0859254822.USD","LU1839511570.USD","SG9999015978.USD","IBBQ","LU0861579265.USD","BK4568","LU1934455277.USD","LU2089984988.USD","GILD","LU1571399168.USD","BK4566","BMED","LU0114720955.EUR","LU2324357040.USD","BIB","IE00BSNM7G36.USD","LU0058720904.USD","LU1066053197.SGD","BK4588","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4532","LU0882574055.USD","BK4583","TBXU","LU0320765992.SGD","TMED","LU1023059063.AUD","IBB","LU1778281490.HKD","LU1934455194.USD","LU0234570918.USD","BK4578","BK4585","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2112291526.USD","LU0823416689.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0889565916.HKD","LU2468319806.SGD","LU0965509283.SGD","LU1839511570.USD","BBH","LU1037948897.HKD","LU1571399168.USD","LU0320765992.SGD","MEDI","LU1934455194.USD","TMED","BK4585","BK4578","BMED","IBB","LU0289739699.SGD","LU0965509010.AUD","LU0859254822.USD","LU0965509101.SGD","IBBQ","TBXU","LU1057294990.SGD","LU2087621335.USD","IE0002270589.USD","GILD","LU0861579265.USD","LU1066053197.SGD","LU0058720904.USD","LU1778281490.HKD","NRIX","LU0109394709.USD","LU0122379950.USD","SG9999015986.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","BK4583","BK4532","BK4568","BIB","LU1066051498.USD","SG9999015945.SGD","IE00B3T34201.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU1934455277.USD","SG9999015978.USD","LU0882574055.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673724701","title":"Viatris to Report Third-Quarter Financial Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2673724701","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673724701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:59","pubTimestamp":1791197955,"startTime":"0","endTime":"0","summary":"Viatris to report third-quarter financial results, host conference call and webcastViatris will report third-quarter 2026 financial results on Nov. 5, 2026.Conference call, live webcast set for Nov. 5","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL78grD0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VTRS","BK4588","LU2087621335.USD","BK4583","LU1839511570.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704754","title":"Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Could Be Quite Risky","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704754","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704754?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:35","pubTimestamp":1791196539,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tnxp/tonix-pharmaceuticals-holding/news/companies-like-tonix-pharmaceuticals-holding-nasdaqtnxp-coul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tnxp/tonix-pharmaceuticals-holding/news/companies-like-tonix-pharmaceuticals-holding-nasdaqtnxp-coul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QQQM","QQQJ","TQQY","TNXP","QQQE","FTEC","BK4139","QQQY","TECS","QYLG","BK4583",".IXIC","QQQA","QID","NDX","SQQQ","MNQmain","ONEQ","NQmain","QQQ","QLD","PSQ","03086","JEPQ","GPIQ","NVIW.SI","TQQQ","IYW","QDTE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}